BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Masoud V, Pagès G. Targeted therapies in breast cancer: New challenges to fight against resistance. World J Clin Oncol 2017; 8(2): 120-134 [PMID: 28439493 DOI: 10.5306/wjco.v8.i2.120]
URL: https://www.wjgnet.com/2218-4333/full/v8/i2/120.htm
Number Citing Articles
1
Lisa König, Fabian D. Mairinger, Oliver Hoffmann, Ann-Kathrin Bittner, Kurt W. Schmid, Rainer Kimmig, Sabine Kasimir-Bauer, Agnes Bankfalvi. Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancerBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5320-2
2
Xiao Jian Tan, Wai Loon Cheor, Ee Meng Cheng, Khairul Shakir Ab Rahman, Wan Zuki Azman Wan Muhamad, Wai Zhe Leow. Breast cancer status, grading system, etiology, and challenges in Asia: an updated reviewOncologie 2023; 25(2): 99 doi: 10.1515/oncologie-2022-1011
3
K. Pather, T. N. Augustine. Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivoScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75779-y
4
Nemany A.N. Hanafy. Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancerInternational Journal of Biological Macromolecules 2021; 182: 1981 doi: 10.1016/j.ijbiomac.2021.05.149
5
Ching-Hsuan Liu, Sy-Jye Leu, Chi-Hsin Lee, Cheng-Yuan Lin, Wei-Chu Wang, Bor-Yu Tsai, Yu-Ching Lee, Chi-Long Chen, Yi-Yuan Yang, Liang-Tzung Lin. Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1292019
6
Marina Petrenko, Antje Güttler, Anne Funtan, Jacqueline Keßler, Daniel Emmerich, Reinhard Paschke, Dirk Vordermark, Matthias Bache. Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cellsChemico-Biological Interactions 2021; 333: 109326 doi: 10.1016/j.cbi.2020.109326
7
Joel Vidal Verdaguer, Robert Martí Marly, Hilde Bosmans, Nicholas Marshall, Chantal Van Ongeval. Using deep learning for triple-negative breast cancer classification in DCE-MRI16th International Workshop on Breast Imaging (IWBI2022) 2022; : 44 doi: 10.1117/12.2625780
8
S. Krajnak, C. Schnatz, K. Almstedt, W. Brenner, F. Haertner, A.-S. Heimes, A. Lebrecht, G.-M. Makris, R. Schwab, A. Hasenburg, M. Schmidt, M. J. Battista. Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control studyBreast Cancer Research and Treatment 2020; 182(2): 389 doi: 10.1007/s10549-020-05711-5
9
Yogita Chhichholiya, Prabhat Suman, Sandeep Singh, Anjana Munshi. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategiesMedical Oncology 2021; 38(8) doi: 10.1007/s12032-021-01547-1
10
Eugena Stamuli, Sorcha Corry, Derek Ross, Thomais Konstantopoulou, Luis Texeira, Bernard Avouac, Dominique Debiais, Liz Yates, Arni Behis, Ambrose McLoughlin, Federacja Stowarzyszeń Amazonki, Maciej Niewada, Ana Casas, Jaime Espin. Patient Preferences for Breast Cancer Treatments: A Discrete Choice Experiment in France, Ireland, Poland and SpainFuture Oncology 2022; 18(9): 1115 doi: 10.2217/fon-2021-0635
11
Takeo Tatsuta, Masahiro Hosono. Glycosignals in Cancer2023; : 125 doi: 10.1007/978-981-19-7732-9_7
12
Cheng Zhang, Jiao‐jiao Yu, Chen Yang, Shuang Shang, Xiao‐xi Lv, Bing Cui, Fang Hua. Crosstalk between ferroptosis and stress—Implications in cancer therapeutic responsesCancer Innovation 2022; 1(1): 92 doi: 10.1002/cai2.7
13
Eun Jung Sohn, Deok-Beom Jung, HyoJung Lee, Ihn Han, Jihyun Lee, Hyemin Lee, Sung-Hoon Kim. CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cellsCancer Letters 2018; 412: 88 doi: 10.1016/j.canlet.2017.09.052
14
Kyaw Zin Thein, Thura Win Htut, Somedeb Ball, Sriman Swarup, Anita Sultan, Thein Hlaing Oo. Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trialsBreast Cancer Research and Treatment 2020; 183(2): 479 doi: 10.1007/s10549-020-05783-3
15
Kanika Verma, Panupong Mahalapbutr, Atima Auepattanapong, Onnicha Khaikate, Chutima Kuhakarn, Kaito Takahashi, Thanyada Rungrotmongkol. Molecular dynamics simulations of sulfone derivatives in complex with DNA topoisomerase IIα ATPase domainJournal of Biomolecular Structure and Dynamics 2022; 40(4): 1692 doi: 10.1080/07391102.2020.1831961
16
Bárbara Costa, Irina Amorim, Fátima Gärtner, Nuno Vale. Understanding Breast cancer: from conventional therapies to repurposed drugsEuropean Journal of Pharmaceutical Sciences 2020; 151: 105401 doi: 10.1016/j.ejps.2020.105401
17
Winfrey Pui Yee Hoo, Pui Yan Siak, Lionel L.A. In. Overview of Current Immunotherapies Targeting Mutated KRAS CancersCurrent Topics in Medicinal Chemistry 2019; 19(23): 2158 doi: 10.2174/1568026619666190904163524
18
PalashKumar Mandal, Anindya Adhikari, Subir Biswas, Amita Giri, Arnab Gupta, Arindam Bhattacharya. Comparison of histopathological grading and staging of breast cancer with p53-positive and transforming growth factor-beta receptor 2-negative immunohistochemical marker expression casesCancer Translational Medicine 2020; 6(2): 30 doi: 10.4103/ctm.ctm_4_20
19
Mohini Guleria, Rohit Sharma, Jeyachitra Amirdhanayagam, Haladhar D. Sarma, Venkatesh Rangarajan, Ashutosh Dash, Tapas Das. Formulation and clinical translation of [177Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancerRSC Medicinal Chemistry 2021; 12(2): 263 doi: 10.1039/D0MD00319K
20
Wajana Lako LABISSO. Status of Pathology Services and Molecular Pathology in Sub-Saharan Africa: Implications for Combating Breast CancerKorean Journal of Clinical Laboratory Science 2023; 55(3): 121 doi: 10.15324/kjcls.2023.55.3.121
21
Baha’ Sharaf, Abdelrahman Hajahjeh, Hira Bani Hani, Hikmat Abdel-Razeq. Next generation selective estrogen receptor degraders in postmenopausal women with advanced-stage hormone receptors-positive, HER2-negative breast cancerFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1385577
22
Sho Ueno, Min Woo Kim, Gibok Lee, Yong Il Park, Takuro Niidome, Ruda Lee. Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast CancerPharmaceutics 2020; 12(6): 585 doi: 10.3390/pharmaceutics12060585
23
Avia D. Wilkerson, Corey K. Gentle, Camila Ortega, Zahraa Al-Hilli. Disparities in Breast Cancer Care—How Factors Related to Prevention, Diagnosis, and Treatment Drive InequityHealthcare 2024; 12(4): 462 doi: 10.3390/healthcare12040462
24
Cijo George Vazhappilly, Rawad Hodeify, Shoib Sarwar Siddiqui, Amina Jamal Laham, Varsha Menon, Raafat El‐Awady, Rachel Matar, Maxime Merheb, John Marton, Hussain Abdel Karim Al Zouabi, Rajan Radhakrishnan. Natural compound catechol induces DNA damage, apoptosis, and G1 cell cycle arrest in breast cancer cellsPhytotherapy Research 2021; 35(4): 2185 doi: 10.1002/ptr.6970
25
Mohammad Tabrizi, Daping Zhang, Vaishnavi Ganti, Glareh Azadi. Integrative Pharmacology: Advancing Development of Effective ImmunotherapiesThe AAPS Journal 2018; 20(4) doi: 10.1208/s12248-018-0229-2
26
Jenny M. Hogstrom, Kayla A. Cruz, Laura M. Selfors, Madelyn N. Ward, Tejas S. Mehta, Naama Kanarek, Jordana Philips, Vandana Dialani, Gerburg Wulf, Laura C. Collins, Jaymin M. Patel, Taru Muranen. Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanismsJournal of Biological Chemistry 2023; 299(8): 105021 doi: 10.1016/j.jbc.2023.105021
27
Vítor Yang, Maria João Gouveia, Joana Santos, Beate Koksch, Irina Amorim, Fátima Gärtner, Nuno Vale. Breast cancer: insights in disease and influence of drug methotrexateRSC Medicinal Chemistry 2020; 11(6): 646 doi: 10.1039/D0MD00051E
28
Xing Ke, Lisong Shen. Molecular targeted therapy of cancer: The progress and future prospectFrontiers in Laboratory Medicine 2017; 1(2): 69 doi: 10.1016/j.flm.2017.06.001
29
Duna H. Barakeh, Rasha Aljelaify, Yara Bashawri, Amal Almutairi, Fatimah Alqubaishi, Mohammed Alnamnakani, Latifa Almubarak, Abdulrahman Al Naeem, Fatema Almushawah, May Alrashed, Malak Abedalthagafi. Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patientsOncotarget 2021; 12(7): 686 doi: 10.18632/oncotarget.27909
30
Molly M Morgan, Linda A Schuler, Jordan C Ciciliano, Brian P Johnson, Elaine T Alarid, David J Beebe. Modeling chemical effects on breast cancer: the importance of the microenvironment in vitroIntegrative Biology 2020; 12(2): 21 doi: 10.1093/intbio/zyaa002
31
Yinji Cui, Meiying Song, Su Young Kim. Prognostic significance of fatty acid binding protein‐4 in the invasive ductal carcinoma of the breastPathology International 2019; 69(2): 68 doi: 10.1111/pin.12756
32
Rui-Zhi Tang, Zhen-Zhen Liu, Sai-Sai Gu, Xi-Qiu Liu. Multiple local therapeutics based on nano-hydrogel composites in breast cancer treatmentJournal of Materials Chemistry B 2021; 9(6): 1521 doi: 10.1039/D0TB02737E
33
Deborah O. Onwusah, Elizabeth B. Ojewole, Moses J. Chimbari. Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping ReviewJCO Global Oncology 2023; (9) doi: 10.1200/GO.21.00289
34
Christian Rafael Quijia, Andreina Quevedo Enríquez, Carlos Daniel Zappia, Roxana Noemí Peroni, Marlus Chorilli. Administration of Inhibitory Molecules through Nanoparticles in Breast Cancer TherapyCurrent Medicinal Chemistry 2024; 31(6): 726 doi: 10.2174/0929867330666230608145125
35
Min-Gu Lee, Hyun-Jin Hong, Kyung-Soo Nam. Anthocyanin Oligomers Induce Apoptosis and Autophagy by Inhibiting the mTOR Signaling Pathway in Human Breast Cancer CellsPharmaceuticals 2023; 17(1): 24 doi: 10.3390/ph17010024
36
Huayan Ren, Xiaoyi Mi, Pengyuan Zhao, Xueyan Zhao, Na Wei, Huifen Huang, Zhongqin Meng, Junna Kou, Mingfang Sun, Yuqiong Liu, Hongyan Zhang, Jianping Yang, Wencai Li, Huixiang Li. TRAF4, a new substrate of SIAH1, participates in chemotherapy resistance of breast cancer cell by counteracting SIAH1-mediated downregulation of β-cateninBreast Cancer Research and Treatment 2020; 183(2): 275 doi: 10.1007/s10549-020-05789-x
37
Yanamandala Nitheesh, Rajesh Pradhan, Siddhant Hejmady, Rajeev Taliyan, Gautam Singhvi, Amit Alexander, Prashant Kesharwani, Sunil Kumar Dubey. Surface engineered nanocarriers for the management of breast cancerMaterials Science and Engineering: C 2021; 130: 112441 doi: 10.1016/j.msec.2021.112441
38
Carmen Chan, Bernard Law, Winnie So, Ka Chow, Mary Waye. Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An UpdateInternational Journal of Molecular Sciences 2017; 18(11): 2423 doi: 10.3390/ijms18112423
39
Sulieman Ibraheem Shelash Al-Hawary, Ebraheem Abdu Musad Saleh, Nodirjon Akhmetovich Mamajanov, Nataliya S. Gilmanova, Hashem O. Alsaab, Adel Alghamdi, Shakeel Ahmed Ansari, Ahmed Hussien Radie Alawady, Ali Hashiem Alsaalamy, Ahmed Jaber Ibrahim. Breast cancer vaccines; A comprehensive and updated reviewPathology - Research and Practice 2023; 249: 154735 doi: 10.1016/j.prp.2023.154735
40
Mah Noor Zafar, William G. Pitt, Ghaleb A. Husseini. Encapsulation and release of calcein from herceptin-conjugated eLiposomesHeliyon 2024; 10(6): e27882 doi: 10.1016/j.heliyon.2024.e27882
41
Pankaj Kumar, Bharti Mangla, Shamama Javed, Waquar Ahsan, Pankaj Musyuni, Durgaramani Sivadasan, Saad S. Alqahtani, Geeta Aggarwal. A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapyFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1149554
42
N A Saeed, I H Hamzah, S I Mahmood. The applications of nano-medicine in the breast cancer therapyJournal of Physics: Conference Series 2021; 1853(1): 012061 doi: 10.1088/1742-6596/1853/1/012061
43
Elena-Georgiana Dobre, Sorina Dinescu, Marieta Costache. Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast CancerCancers 2020; 12(9): 2698 doi: 10.3390/cancers12092698
44
Nam Ho Jeoung, Ae Lim Jo, Hee Sung Park. Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cellsBiochemical and Biophysical Research Communications 2021; 558: 22 doi: 10.1016/j.bbrc.2021.04.054
45
Agata Binienda, Sylwia Ziolkowska, Elzbieta Pluciennik. The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast CancerAnti-Cancer Agents in Medicinal Chemistry 2020; 20(15): 1787 doi: 10.2174/1871520620666191220142741
46
Marcella R. Cardoso, Alex Ap. Rosini Silva, Maria Cecília R. Talarico, Pedro H. Godoy Sanches, Maurício L. Sforça, Silvana A. Rocco, Luciana M. Rezende, Melissa Quintero, Tassia B. B. C. Costa, Laís R. Viana, Rafael R. Canevarolo, Amanda C. Ferracini, Susana Ramalho, Junier Marrero Gutierrez, Fernando Guimarães, Ljubica Tasic, Alessandra Tata, Luís O. Sarian, Leo L. Cheng, Andreia M. Porcari, Sophie F. M. Derchain. Metabolomics by NMR Combined with Machine Learning to Predict Neoadjuvant Chemotherapy Response for Breast CancerCancers 2022; 14(20): 5055 doi: 10.3390/cancers14205055
47
Perrine Courlet, Evelina Cardoso, Carole Bandiera, Athina Stravodimou, Jean-Philippe Zurcher, Haithem Chtioui, Isabella Locatelli, Laurent Arthur Decosterd, Léa Darnaud, Benoit Blanchet, Jérôme Alexandre, Anna Dorothea Wagner, Khalil Zaman, Marie Paule Schneider, Monia Guidi, Chantal Csajka. Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast CancerPharmaceutics 2022; 14(7): 1317 doi: 10.3390/pharmaceutics14071317
48
Melike Tepe, Şebnem Abadan, Mehmet F. Saglam, Veysel Süzerer, Pelin Balçık Erçin, Devrim Atilla, Esma Erciyas Baykal, Mine Gül Şeker, Tamer Yağcı, Yelda Özden Çiftçi. In vitro mass production, chemical modification, and cytotoxicity of shikonin derivatives on breast cancer cellsIndustrial Crops and Products 2023; 192: 116087 doi: 10.1016/j.indcrop.2022.116087
49
Elda A. Flores-Contreras, Everardo Gonz醠ez-Gonz醠ez, Ana I. Zaraz鷄-Ni駉, Elsa N. Garza-Trevi駉, Natalia Mart韓ez-Acu馻, Viviana C. Zomosa-Signoret, Rom醤 Vidaltamayo, Gerardo E. Mu駉z-Maldonado, Raquel Garza-Guajardo, Manuel de J. Garc韆-Sol韘, Alejandro Abarca-Blanco, Ana M. G. Rivas-Estilla, Carlos C髍dova-Fletes. Overexpression of lnc-ERP44-3:6 Causes Cell Death and Sensitivity to Cisplatin in Breast Cancer Cell LinesOncologie 2021; 23(3): 373 doi: 10.32604/oncologie.2021.017786
50
Edina H. Avdović, Žiko B. Milanović, Marko N. Živanović, Dragana S. Šeklić, Ivana D. Radojević, Ljiljana R. Čomić, Srećko R. Trifunović, Ana Amić, Zoran S. Marković. Synthesis, spectroscopic characterization, biological activity, DFT and molecular docking study of novel 4-hydroxycoumarine derivatives and corresponding palladium(II) complexesInorganica Chimica Acta 2020; 504: 119465 doi: 10.1016/j.ica.2020.119465
51
Pedram Ebrahimnejad, Zahra Mohammadi, Amirhossein Babaei, Melika Ahmadi, Shervin Amirkhanloo, Kofi Asare-Addo, Ali Nokhodchid. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications Critical Reviews™ in Therapeutic Drug Carrier Systems 2024; 41(1): 35 doi: 10.1615/CritRevTherDrugCarrierSyst.v41.i1.20
52
Arpita Pandey Tiwari, Sonali S. Rohiwal. Nanomedicines for Breast Cancer Theranostics2020; : 351 doi: 10.1016/B978-0-12-820016-2.00015-X
53
Venugopal R. Bovilla, Mahadevaswamy G. Kuruburu, Vidya G. Bettada, Jayashree Krishnamurthy, Olga A. Sukocheva, Rajesh K. Thimmulappa, Nanjunda Swamy Shivananju, Janardhan P. Balakrishna, SubbaRao V. Madhunapantula. Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In VivoBiomedicines 2021; 9(9): 1119 doi: 10.3390/biomedicines9091119
54
Sai Kiran S.S. Pindiprolu, Jitender Madhan, Dadi A. Srinivasarao, Nagasen Dasari, Chirravuri. S. Phani Kumar, Chantibabu Katta, Vaskuri G.S. Sainaga Jyothi. Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancerJournal of Drug Delivery Science and Technology 2023; 86: 104617 doi: 10.1016/j.jddst.2023.104617
55
Zeinab Safarpour Lima, Mostafa Ghadamzadeh, Farzad Tahmasebi Arashloo, Ghazaleh Amjad, Mohammad Reza Ebadi, Ladan Younesi. Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigmsJournal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0725-6
56
Sina M. Matalqah, Khalid Aiedeh, Nizar M. Mhaidat, Karem H. Alzoubi, Belal A. AL-Husein. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer CellsCurrent Cancer Drug Targets 2022; 22(2): 133 doi: 10.2174/1568009622666220126100532
57
Nidhi Jyotsana, Zhenjiang Zhang, Lauren E. Himmel, Fang Yu, Michael R. King. Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resectionScience Advances 2019; 5(7) doi: 10.1126/sciadv.aaw4197
58
Mohsen Salehi, Jafar Razmara, Shahriar Lotfi, Farnaz Mahan. A One-Dimensional Probabilistic Convolutional Neural Network for Prediction of Breast Cancer SurvivabilityThe Computer Journal 2021;  doi: 10.1093/comjnl/bxab096
59
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence2022; : 27 doi: 10.1007/978-3-031-10839-6_2
60
Mark Uhlik, Daniel Pointing, Seema Iyer, Luka Ausec, Miha Štajdohar, Robert Cvitkovič, Matjaž Žganec, Kerry Culm, Valerie Chamberlain Santos, Bronislaw Pytowski, Mokenge Malafa, Hong Liu, Arthur M. Krieg, Jeeyun Lee, Rafael Rosengarten, Laura Benjamin. Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancersFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1158345
61
Vijay Sagar Madamsetty, Shima Tavakol, Saeid Moghassemi, Arezoo Dadashzadeh, John D. Schneible, Iman Fatemi, Abdolsamad Shirvani, Ali Zarrabi, Fereshteh Azedi, Ali Dehshahri, Abbas Aghaei Afshar, Kian Aghaabbasi, Abbas Pardakhty, Reza Mohammadinejad, Prashant Kesharwani. Chitosan: A versatile bio-platform for breast cancer theranosticsJournal of Controlled Release 2022; 341: 733 doi: 10.1016/j.jconrel.2021.12.012
62
Nilesh Rai, Priyamvada Gupta, Ashish Verma, Santosh Kumar Singh, Vibhav Gautam. Isolation and characterization of N‐(2‐Hydroxyethyl)hexadecanamide from Colletotrichum gloeosporioides with apoptosis‐inducing potential in breast cancer cellsBioFactors 2023; 49(3): 663 doi: 10.1002/biof.1940
63
Manoj Kumar Dash, Namrata Joshi, D.N.S Gautam, Remya Jayakumar, Y.B. Tripathi. Ayurvedic supportive therapy in the management of breast cancerJournal of Herbal Medicine 2021; 29: 100490 doi: 10.1016/j.hermed.2021.100490
64
Mohammad Azam Ansari, Muthu Thiruvengadam, Zeba Farooqui, Govindaswamy Rajakumar, Qazi Mohammad Sajid Jamal, Mohammad A. Alzohairy, Ahmad Almatroudi, Mohammad N. Alomary, Ill-Min Chung, Ebtesam Abdullah Al-Suhaimi. Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancerSeminars in Cancer Biology 2021; 69: 109 doi: 10.1016/j.semcancer.2019.12.022
65
Claudia Rossi, Ilaria Cicalini, Maria Concetta Cufaro, Ada Consalvo, Prabin Upadhyaya, Gianluca Sala, Ivana Antonucci, Piero Del Boccio, Liborio Stuppia, Vincenzo De Laurenzi. Breast cancer in the era of integrating “Omics” approachesOncogenesis 2022; 11(1) doi: 10.1038/s41389-022-00393-8
66
Kitti Andreidesz, Aliz Szabo, Dominika Kovacs, Balazs Koszegi, Viola Bagone Vantus, Eszter Vamos, Mostafa Isbera, Tamas Kalai, Zita Bognar, Krisztina Kovacs, Ferenc Gallyas. Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer LinesInternational Journal of Molecular Sciences 2021; 22(16): 9016 doi: 10.3390/ijms22169016
67
Hilda Amekyeh, Enas Alkhader, Rayan Sabra, Nashiru Billa. Prospects of Curcumin Nanoformulations in Cancer ManagementMolecules 2022; 27(2): 361 doi: 10.3390/molecules27020361
68
Kitti Andreidesz, Balazs Koszegi, Dominika Kovacs, Viola Bagone Vantus, Ferenc Gallyas, Krisztina Kovacs. Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer CellsInternational Journal of Molecular Sciences 2021; 22(4): 2056 doi: 10.3390/ijms22042056
69
Evgenii L. Guryev, Natalia O. Volodina, Natalia Y. Shilyagina, Sergey V. Gudkov, Irina V. Balalaeva, Arthur B. Volovetskiy, Alexander V. Lyubeshkin, Alexey V. Sen’, Sergey A. Ermilov, Vladimir A. Vodeneev, Rem V. Petrov, Andrei V. Zvyagin, Zhores I. Alferov, Sergey M. Deyev. Radioactive ( 90 Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer Proceedings of the National Academy of Sciences 2018; 115(39): 9690 doi: 10.1073/pnas.1809258115
70
Jac A. Nickoloff, Aruna S. Jaiswal, Neelam Sharma, Elizabeth A. Williamson, Manh T. Tran, Dominic Arris, Ming Yang, Robert Hromas. Cellular Responses to Widespread DNA Replication StressInternational Journal of Molecular Sciences 2023; 24(23): 16903 doi: 10.3390/ijms242316903
71
Sufia Islam, Nazia Hoque, Nishat Nasrin, Mehnaz Hossain, Farhana Rizwan, Kushal Biswas, Muhammad Asaduzzaman, Sabera Rahman, David W. Hoskin, Saki Sultana, Christian Lehmann. Iron Overload and Breast Cancer: Iron Chelation as a Potential Therapeutic ApproachLife 2022; 12(7): 963 doi: 10.3390/life12070963
72
Anna Barkovskaya, Kotryna Seip, Lina Prasmickaite, Ian G. Mills, Siver A. Moestue, Harri M. Itkonen. Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cellsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-74083-z
73
Bing Wang, Yueping Wang, Xuedong Wang, Juan Gu, Wenyong Wu, Huaiguo Wu, Qingping Wang, Daoping Zhou, Rohit Gundamaraju. Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling PathwayDisease Markers 2022; 2022: 1 doi: 10.1155/2022/5762686
74
Baranya Murugan, Uma Maheswari Krishnan. Differently Sized Drug-Loaded Mesoporous Silica Nanoparticles Elicit Differential Gene Expression in MCF-7 Cancer CellsNanomedicine 2021; 16(12): 1017 doi: 10.2217/nnm-2020-0375
75
Anastasia Murtha-Lemekhova, Juri Fuchs, Erik Schulz, Anthe Suzan Sterkenburg, Philipp Mayer, Jan Pfeiffenberger, Katrin Hoffmann. Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological FeaturesJournal of Hepatocellular Carcinoma 2021; : 1269 doi: 10.2147/JHC.S328198
76
Sarvesh Kumar Verma, Arpon Biswas, Mukesh Kumar, Anjali Mishra, Abhijit Deb Choudhury, Sristi Agrawal, Sachin Nashik Sanap, Amol Chhatrapati Bisen, Ashok Kumar Sharma, Gautam Panda, Rabi Sankar Bhatta. Preclinical pharmacokinetics, CYP phenotyping, and tissue distribution study of novel anti-breast cancer candidate S-011-1559Xenobiotica 2022; 52(5): 476 doi: 10.1080/00498254.2022.2101033
77
Lara Pierantoni, Virginia Brancato, João B. Costa, Subhas C. Kundu, Rui L. Reis, Joana Silva‐Correia, Joaquim M. Oliveira. Synergistic Effect of Co‐Culturing Breast Cancer Cells and Fibroblasts in the Formation of Tumoroid Clusters and Design of In Vitro 3D Models for the Testing of Anticancer AgentsAdvanced Biology 2023; 7(4) doi: 10.1002/adbi.202200141
78
Matthew R. Liebers. Detection Methods in Precision Medicine2020; : 345 doi: 10.1039/9781788019958-00345
79
Nilesh Raghunath Khedkar, Alex Joseph, Milind Sindkhedkar. Design, synthesis, and characterization of 3-(2-(pyrimidin-5-yl)thiazol-4-yl)-1,2,4-oxadiazole derivatives: Anticancer and molecular docking investigationsSynthetic Communications 2024; 54(2): 144 doi: 10.1080/00397911.2023.2287796
80
Shubhank Sherekar, Ganesh A. Viswanathan. Boolean dynamic modeling of cancer signaling networks: Prognosis, progression, and therapeuticsComputational and Systems Oncology 2021; 1(2) doi: 10.1002/cso2.1017
81
Shailendra Dwivedi, Ruchika Agrawal, Radhieka Misra, Saba Anjum, Sudhir Shyam Kushwaha, Hari Shanker Joshi, Sanjeev Misra, Surekha Kishore. Biotechnology in Healthcare2022; : 3 doi: 10.1016/B978-0-323-90042-3.00012-8
82
Yu. A. Shevchenko, M. S. Kuznetsova, A. A. Khristin, S. V. Sidorov, S. V. Sennikov. Modern breast cancer therapy: from tamoxifen to T-cell engineeringSiberian journal of oncology 2022; 21(5): 109 doi: 10.21294/1814-4861-2022-21-5-109-122
83
Fernanda Malhão, Alice Ramos, Ana Macedo, Eduardo Rocha. Cytotoxicity of Seaweed Compounds, Alone or Combined to Reference Drugs, against Breast Cell Lines Cultured in 2D and 3DToxics 2021; 9(2): 24 doi: 10.3390/toxics9020024
84
Farnaz Khodabakhsh, Shima Shokri, Neda Jalili, Shima Moradi-Kalbolandi, Fariba Dashtestani, Leila Farahmand. Anti-MUC1 nanobody conjugated by chitosan nanoparticle with enhancement of anti-proliferation activity in breast cancer cell linesChemical Papers 2023; 77(4): 2229 doi: 10.1007/s11696-022-02625-y
85
Mohammad Sadegh Taghizadeh, Ali Niazi, Ali Moghadam, Alireza Afsharifar, Jie Zheng. Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancerPLOS ONE 2022; 17(5): e0267961 doi: 10.1371/journal.pone.0267961
86
Nilofer Shaikh, Sanket Bapat, Muthukumarasamy Karthikeyan, Renu Vyas. A Review on Computational Analysis of Big Data in Breast Cancer for Predicting Potential BiomarkersCurrent Topics in Medicinal Chemistry 2022; 22(21): 1793 doi: 10.2174/1568026622666220907121942
87
Akanksha Behl, Zahoor A. Wani, Nagendra Nath Das, Virinder S. Parmar, Christophe Len, Shashwat Malhotra, Anil K. Chhillar. Monoclonal antibodies in breast cancer: A critical appraisalCritical Reviews in Oncology/Hematology 2023; 183: 103915 doi: 10.1016/j.critrevonc.2023.103915
88
Nam Ji Sung, Na Hui Kim, Na Young Bae, Hyo Sik Jo, Sin-Aye Park. DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cellsBioscience Reports 2020; 40(3) doi: 10.1042/BSR20200164
89
David Enoma. Genomics in Clinical trials for Breast CancerBriefings in Functional Genomics 2023;  doi: 10.1093/bfgp/elad054
90
Alexander Atkins, Pratyush Gupta, Bing Melody Zhang, Wen-Sy Tsai, Julian Lucas, Manana Javey, Anagh Vora, Rui Mei. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy SelectionMolecular Diagnosis & Therapy 2019; 23(4): 521 doi: 10.1007/s40291-019-00406-0
91
Yuanyuan He, Raimundo Fernandes de Araújo Júnior, Rômulo S. Cavalcante, Zhenfeng Yu, Timo Schomann, Zili Gu, Christina Eich, Luis J. Cruz. Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticlesBiomaterials Advances 2023; 145: 213270 doi: 10.1016/j.bioadv.2022.213270
92
Pang-Hung Hsu, Wei-Hsuan Chen, Chen Juan-Lu, Shu-Chen Hsieh, Shih-Chao Lin, Ru-Tsun Mai, Shiow-Yi Chen. Hesperidin and Chlorogenic Acid Synergistically Inhibit the Growth of Breast Cancer Cells via Estrogen Receptor/Mitochondrial PathwayLife 2021; 11(9): 950 doi: 10.3390/life11090950
93
Narendra Wajapeyee, Romi Gupta. Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer TherapiesCancer Research 2021; 81(22): 5589 doi: 10.1158/0008-5472.CAN-21-1606
94
Khadijeh Moradi, Farnaz Barneh, Saeed Irian, Mohsen Amini, Raheleh Moradpoor, Amir Amanzadeh, Samira Choopani, Hamzeh Rahimi, Tayebeh Ghodselahi, Massoud M. Boujar, Mona Salimi. Two Novel Tri-Aryl Derivatives Attenuate the Invasion-Promoting Effects of Stromal Mesenchymal Stem Cells on Breast CancerAnti-Cancer Agents in Medicinal Chemistry 2019; 19(8): 1002 doi: 10.2174/1871520619666190212123912
95
Kristina Witt, Maarten A. Ligtenberg, Laura Conti, Stefania Lanzardo, Roberto Ruiu, Tatjana Wallmann, Helena Tufvesson-Stiller, Benedict J. Chambers, Charlotte Rolny, Alvaro Lladser, Andreas Lundqvist, Federica Cavallo, Rolf Kiessling. Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary CarcinomaCancer Immunology Research 2018; 6(11): 1417 doi: 10.1158/2326-6066.CIR-17-0572
96
Susinjan Bhattacharya. Metabolic Reprogramming and Cancer: 2022Qeios 2022;  doi: 10.32388/CK9VJB.3
97
Sharath Mohan Bhat, Palla Ranga Prasad, Manjunath B. Joshi. Epigenetic Regulation of Cancer - Part AInternational Review of Cell and Molecular Biology 2023; 380: 63 doi: 10.1016/bs.ircmb.2023.04.002
98
A. P. L. Sabino, L. M. S. Eustáquio, A. C. F. Miranda, C. Biojone, T. N. Mariosa, Cibele Marli Cação Paiva Gouvêa. Stryphnodendron adstringens (“Barbatimão”) Leaf Fraction: Chemical Characterization, Antioxidant Activity, and Cytotoxicity Towards Human Breast Cancer Cell LinesApplied Biochemistry and Biotechnology 2018; 184(4): 1375 doi: 10.1007/s12010-017-2632-z
99
Mandana T. Manzari, Yosi Shamay, Hiroto Kiguchi, Neal Rosen, Maurizio Scaltriti, Daniel A. Heller. Targeted drug delivery strategies for precision medicinesNature Reviews Materials 2021; 6(4): 351 doi: 10.1038/s41578-020-00269-6
100
Michele Massimino, Paolo Vigneri, Stefania Stella, Elena Tirrò, Maria Stella Pennisi, Laura Nunziatina Parrinello, Calogero Vetro, Livia Manzella, Fabio Stagno, Francesco Di Raimondo. Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic CellsJournal of Clinical Medicine 2021; 10(23): 5606 doi: 10.3390/jcm10235606
101
Chang Yang, Yu Jiang, Sai Heng Hao, Xing Yi Yan, De Fei Hong, Hua Naranmandura. Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapyJournal of Materials Chemistry B 2022; 10(1): 20 doi: 10.1039/D1TB02098F
102
Juan Jin, Zijia Sun, Fang Yang, Lin Tang, Weiwei Chen, Xiaoxiang Guan. miR-19b-3p inhibits breast cancer cell proliferation and reverses saracatinib-resistance by regulating PI3K/Akt pathwayArchives of Biochemistry and Biophysics 2018; 645: 54 doi: 10.1016/j.abb.2018.03.015
103
Lingyuan Ma, Chenyu Li, Hanlin Yin, Jiashu Huang, Shenghao Yu, Jin Zhao, Yongxu Tang, Min Yu, Jie Lin, Lei Ding, Qinghua Cui. The Mechanism of DNA Methylation and miRNA in Breast CancerInternational Journal of Molecular Sciences 2023; 24(11): 9360 doi: 10.3390/ijms24119360
104
Alaa Mohamed Maria, Mohamed El-Shebiney, Ayman Mohamed El-Saka, Yomna Zamzam. Expression of truncated HER2 and its prognostic value in HER2-positive breast cancer patientsJournal of the Egyptian National Cancer Institute 2018; 30(2): 49 doi: 10.1016/j.jnci.2018.05.001
105
Stella D’Oronzo, Domenica Lovero, Raffaele Palmirotta, Luigia Stefania Stucci, Marco Tucci, Claudia Felici, Eliano Cascardi, Carmela Giardina, Paola Cafforio, Franco Silvestris. Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancerScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53660-x
106
Shweta Satpathi, Sagar S Gaurkar, Ashwini Potdukhe, Mayur B Wanjari. Unveiling the Role of Hormonal Imbalance in Breast Cancer Development: A Comprehensive ReviewCureus 2023;  doi: 10.7759/cureus.41737
107
Syazalina Zahari, Saiful Effendi Syafruddin, M. Aiman Mohtar. Impact of the Cancer Cell Secretome in Driving Breast Cancer ProgressionCancers 2023; 15(9): 2653 doi: 10.3390/cancers15092653
108
Navya Ajitkumar Bhaskaran, Naga Thirumalesh Chevala, Lalit Kumar. Nanomedicines for Breast Cancer Theranostics2020; : 245 doi: 10.1016/B978-0-12-820016-2.00011-2
109
Alexandre Holzbach Júnior, Bernardo Perin Cima, Mari Dalva Staffen, Juliana Dal-Ri Lindenau, Yara Costa Netto Muniz. A Review and Meta-analysis on Trastuzumab Resistance in Patients with HER2+ Breast CancerMini-Reviews in Medicinal Chemistry 2023; 23(11): 1222 doi: 10.2174/1389557523666230224110738
110
Komang Suma Triyasa, Ajeng Diantini, Melisa Intan Barliana. A Review of Herbal Medicine-Based Phytochemical of Garcinia as Molecular Therapy for Breast CancerDrug Design, Development and Therapy 2022; : 3573 doi: 10.2147/DDDT.S358229
111
Henan Zhao, Duojiao Li, Baojing Zhang, Yan Qi, Yunpeng Diao, Yuhong Zhen, Xiaohong Shu. PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast CancerMolecules 2017; 22(12): 2277 doi: 10.3390/molecules22122277
112
Shiza Malik, Samra Khalid, Haidar Ali, Maham Khan, Faryal Mehwish, Aneela Javed, Fazal Akbar, Rumeza Hanif, Muhammad Suleman. In-silico modeling and analysis of the therapeutic potential of miRNA-7 on EGFR associated signaling network involved in breast cancerGene Reports 2020; 21: 100938 doi: 10.1016/j.genrep.2020.100938
113
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal, Ankur Vaidya. Nanotechnology Applications for Cancer Chemotherapy2021; : 341 doi: 10.1016/B978-0-12-817846-1.00016-3
114
Fan‐Wei Yang, Te‐Lun Mai, Ying‐Chung Jimmy Lin, Yu‐Chen Chen, Shang‐Che Kuo, Chia‐Ming Lin, Meng‐Hsuan Lee, Jung‐Chen Su. Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancerArchiv der Pharmazie 2024; 357(5) doi: 10.1002/ardp.202300435
115
Salma T. Rafik, Jayant S. Vaidya, Alexander J. MacRobert, Elnaz Yaghini. Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical StudiesJournal of Clinical Medicine 2023; 12(7): 2648 doi: 10.3390/jcm12072648
116
Andreea Crintea, Alina Gabriela Dutu, Gabriel Samasca, Ioan Alexandru Florian, Iulia Lupan, Alexandra Marioara Craciun. The Nanosystems Involved in Treating Lung CancerLife 2021; 11(7): 682 doi: 10.3390/life11070682
117
Panchsheela Ubale, Santosh Mokale, Shweta More, Shailesh Waghamare, Vikramsinh More, Nethaji Munirathinam, Suma Dilipkumar, Rajesh Kumar Das, Sahin Reja, Vasant B Helavi, Shiva Prasad Kollur. Evaluation of in vitro anticancer, antimicrobial and antioxidant activities of new Cu(II) complexes derived from 4(3H)-quinazolinone: Synthesis, crystal structure and molecular docking studiesJournal of Molecular Structure 2022; 1251: 131984 doi: 10.1016/j.molstruc.2021.131984
118
Deeba Khan, Seema Shedole. Leveraging Deep Learning Techniques and Integrated Omics Data for Tailored Treatment of Breast CancerJournal of Personalized Medicine 2022; 12(5): 674 doi: 10.3390/jpm12050674
119
A molecular screening of HER2 inhibitors from Curcuma zedoariaTHE 9TH INTERNATIONAL CONFERENCE OF THE INDONESIAN CHEMICAL SOCIETY ICICS 2021: Toward a Meaningful Society 2022; 2638: 070007 doi: 10.1063/5.0104024
120
Neville Murphy, Elan McCarthy, Róisín Dwyer, Pau Farràs. Boron clusters as breast cancer therapeuticsJournal of Inorganic Biochemistry 2021; 218: 111412 doi: 10.1016/j.jinorgbio.2021.111412
121
Benjamin Daniels, Federico Girosi, Hanna Tervonen, Belinda E. Kiely, Sarah J. Lord, Nehmat Houssami, Sallie-Anne Pearson, Aamir Ahmad. Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016)PLOS ONE 2018; 13(7): e0198152 doi: 10.1371/journal.pone.0198152
122
Prithwish Kola, Prasanth Kumar Bhusetty Nagesh, Pritam Kumar Roy, K. Deepak, Rui Luis Reis, Subhas C. Kundu, Mahitosh Mandal. Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistancesWIREs Nanomedicine and Nanobiotechnology 2023; 15(4) doi: 10.1002/wnan.1876
123
Rita Assi, Nuria Kotecki, Ahmad Awada. Targeting molecular subtypes in solid cancers: successes and failuresCurrent Opinion in Oncology 2020; 32(5): 488 doi: 10.1097/CCO.0000000000000670
124
Anna Egorova, Ivan Pyankov, Marianna Maretina, Vladislav Baranov, Anton Kiselev. Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer CellsPharmaceuticals 2021; 14(10): 957 doi: 10.3390/ph14100957
125
Kristin Calar, Simona Plesselova, Somshuvra Bhattacharya, Megan Jorgensen, Pilar de la Puente. Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment ConcentrationsCancers 2020; 12(7): 1722 doi: 10.3390/cancers12071722
126
Maryam Ahmadzadeh, Farzaneh Farshdari, Mahdi Behdani, Leila Nematollahi, Elham Mohit. Cloning, Expression and One-Step Purification of a Novel IP-10-(anti-HER2 scFv) Fusion Protein in Escherichia coliInternational Journal of Peptide Research and Therapeutics 2021; 27(1): 433 doi: 10.1007/s10989-020-10100-z
127
Imran Ahmad Khan, Noor ul Amin Mohsin, Sana Aslam, Matloob Ahmad. BenzimidazoleBiochemistry 2022; 34 doi: 10.5772/intechopen.101729
128
Hassan Yousefi, Afshin Bahramy, Narges Zafari, Mahsa Rostamian Delavar, Khoa Nguyen, Atousa Haghi, Tahmineh Kandelouei, Cecilia Vittori, Parham Jazireian, Sajad Maleki, Danyal Imani, Amin Moshksar, Amirreza Bitaraf, Sadegh Babashah. Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancerBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10383-z
129
Daniel Y. Lee, Arthur P. Staddon, Jacob E. Shabason, Ronnie Sebro. Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and developmentCancer Medicine 2019; 8(2): 585 doi: 10.1002/cam4.1958
130
Maryam Rashid, Ayesha Maqbool, Nusrat Shafiq, Yousef A. Bin Jardan, Shagufta Parveen, Mohammed Bourhia, Hiba-Allah Nafidi, Rashid Ahmed Khan. The combination of multi-approach studies to explore the potential therapeutic mechanisms of imidazole derivatives as an MCF-7 inhibitor in therapeutic strategiesFrontiers in Chemistry 2023; 11 doi: 10.3389/fchem.2023.1197665
131
Juan P. Muñoz, Pablo Pérez-Moreno, Yasmín Pérez, Gloria M. Calaf. The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical ApplicationDiagnostics 2023; 13(19): 3072 doi: 10.3390/diagnostics13193072
132
Yasmin M. Attia, Salama A. Salama, Samia A. Shouman, Cristina Ivan, Abdelrahman M. Elsayed, Paola Amero, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein. Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancerPharmacological Reports 2022; 74(2): 366 doi: 10.1007/s43440-021-00346-9
133
Narges Dastmalchi, Mohammad Ali Hosseinpourfeizi, Seyed Mahdi Banan Khojasteh, Behzad Baradaran, Reza Safaralizadeh. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathwayLife Sciences 2020; 259: 118239 doi: 10.1016/j.lfs.2020.118239
134
Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast CancerCancers 2019; 11(10): 1614 doi: 10.3390/cancers11101614
135
Violina T. Angelova, Teodora Tatarova, Rositsa Mihaylova, Nikolay Vassilev, Boris Petrov, Zvetanka Zhivkova, Irini Doytchinova. Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity RelationshipsMolecules 2023; 28(5): 2058 doi: 10.3390/molecules28052058
136
Ghazal Mahmoudi, Yahya Ehteshaminia, Parviz Kokhaei, Seyedeh Farzaneh Jalali, Farhad Jadidi-Niaragh, Abdol Sattar Pagheh, Seyed Ehsan Enderami, Saeid Abedian Kenari, Hadi Hassannia. Enhancement of targeted therapy in combination with metformin on human breast cancer cell linesCell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01446-0
137
Pei-Wei Shueng, Lu-Yi Yu, Hsiao-Hsin Hou, Hsin-Cheng Chiu, Chun-Liang Lo. Charge Conversion Polymer–Liposome Complexes to Overcome the Limitations of Cationic Liposomes in Mitochondrial-Targeting Drug DeliveryInternational Journal of Molecular Sciences 2022; 23(6): 3080 doi: 10.3390/ijms23063080
138
Ryan M. Ponec, Parvin Peddi, Rena D. Callahan. PARP Inhibitors in Breast Cancer: Latest EvidenceCurrent Breast Cancer Reports 2017; 9(3): 188 doi: 10.1007/s12609-017-0251-x
139
Luca Andrei, Sandor Kasas, Ignacio Ochoa Garrido, Tijana Stanković, Mónica Suárez Korsnes, Radka Vaclavikova, Yehuda G. Assaraf, Milica Pešić. Advanced technological tools to study multidrug resistance in cancerDrug Resistance Updates 2020; 48: 100658 doi: 10.1016/j.drup.2019.100658
140
Muttiah Barathan, Kumutha Malar Vellasamy, Vanitha Mariappan, Gopinath Venkatraman, Jamuna Vadivelu. Naturally Occurring Phytochemicals to Target Breast Cancer Cell SignalingApplied Biochemistry and Biotechnology 2023;  doi: 10.1007/s12010-023-04734-0
141
Paramita Paul, Sanchita Mandal, Tarun Kumar Dua, Dipika Mandal, R Manasa Deepa. Multifunctional Theranostic Nanomedicines in Cancer2021; : 177 doi: 10.1016/B978-0-12-821712-2.00012-8
142
Mudasir Nabi Peerzada, Rania Hamdy, Masood Ahmad Rizvi, Saurabh Verma. Privileged Scaffolds in Drug Discovery against Human Epidermal Growth Factor Receptor 2 for Cancer TreatmentCurrent Pharmaceutical Design 2023; 29(44): 3563 doi: 10.2174/0113816128283615231218094706
143
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence2022; : 79 doi: 10.1007/978-3-031-10839-6_4
144
Balak Das Kurmi, Rishi Paliwal, Shivani Rai Paliwal. Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approachInternational Journal of Biological Macromolecules 2020; 164: 2881 doi: 10.1016/j.ijbiomac.2020.08.172
145
Harshini Swaminathan, K. Saravanamurali, Sangilimuthu Alagar Yadav. Extensive review on breast cancer its etiology, progression, prognostic markers, and treatmentMedical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02111-9
146
Hangzhen Li, Jianlei Xiao, Xue Li, Qian Huang, Qingfeng Liu, Qing Zhang. Mechanism of morusin on breast cancer via network pharmacology and in vitro experimentsMedicine 2023; 102(28): e34300 doi: 10.1097/MD.0000000000034300
147
Prakash Bansode. Harnessing Medicinal Plants in Cancer Prevention and TreatmentAdvances in Medical Diagnosis, Treatment, and Care 2024; : 239 doi: 10.4018/979-8-3693-1646-7.ch009
148
Prakash Bansode, Pradnya Patil, Prafulla Choudhari, Manish Bhatia, Apurva Birajdar, Indumathi Somasundaram, Gajanan Rashinkar. Anticancer activity and molecular docking studies of ferrocene tethered ionic liquidsJournal of Molecular Liquids 2019; 290: 111182 doi: 10.1016/j.molliq.2019.111182
149
Ubale Panchsheela Ashok, Shiva Prasad Kollur, Nishad Anil, Bansode Prakash Arun, Sanjay Namdev Jadhav, Sanjay Sarsamkar, Vasant Baburao Helavi, Asha Srinivasan, Sandeep Kaulage, Ravindra Veerapur, Sarah Al-Rashed, Asad Syed, Joaquín Ortega-Castro, Juan Frau, Norma Flores-Holguín, Daniel Glossman-Mitnik. Preparation, Spectroscopic Characterization, Theoretical Investigations, and In Vitro Anticancer Activity of Cd(II), Ni(II), Zn(II), and Cu(II) Complexes of 4(3H)-Quinazolinone-Derived Schiff BaseMolecules 2020; 25(24): 5973 doi: 10.3390/molecules25245973
150
Ritihaas Surya Challapalli, Roisin M. Dwyer, Niall McInerney, Michael J. Kerin, Aoife J. Lowery. Effect of Breast Cancer and Adjuvant Therapy on Adipose-Derived Stromal Cells: Implications for the Role of ADSCs in Regenerative Strategies for Breast ReconstructionStem Cell Reviews and Reports 2021; 17(2): 523 doi: 10.1007/s12015-020-10038-1
151
Ishani D. Premaratne, Yoshiko Toyoda, Karel-Bart Celie, Kristy A. Brown, Jason A. Spector. Tissue Engineering Models for the Study of Breast Neoplastic Disease and the Tumor MicroenvironmentTissue Engineering Part B: Reviews 2020; 26(5): 423 doi: 10.1089/ten.teb.2019.0347
152
Rui Wang, Yang Xuan, Yinan Zhao, Wei Wang, Pengfei Ma, Benzhi Ju, Yuhong Zhen, Shubiao Zhang. Cationic Nanoparticulate System for Codelivery of MicroRNA-424 and Podophyllotoxin as a Multimodal Anticancer TherapyMolecular Pharmaceutics 2022; 19(7): 2092 doi: 10.1021/acs.molpharmaceut.1c00962
153
Hui-Yi Xue, Reina Bendayan, Ho-Lun Wong. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy2020; : 121 doi: 10.1016/B978-0-12-816434-1.00005-X
154
Julien Clegg, Maria Koch, Akhilandeshwari Ravichandran, Dietmar W. Hutmacher, Laura J. Bray. Recapitulating the Stem Cell Niche Ex VivoAdvances in Stem Cells and their Niches 2022; 6: 145 doi: 10.1016/bs.asn.2022.02.001
155
Mehdi Roshanian Bakhsh, Leila Rouhi, Kamran Ghaedi, Mehrdad Hashemi, Maryam Peymani, Saeed Samarghandian. Therapeutic effects of guanidine hydrochloride on breast cancer through targeting KCNG1 geneBiomedicine & Pharmacotherapy 2023; 164: 114982 doi: 10.1016/j.biopha.2023.114982
156
Suhrit Dey, Charlie Dey. Mathematical and Computational Studies on Progress, Prognosis, Prevention and Panacea of Breast CancerForum for Interdisciplinary Mathematics 2021; : 257 doi: 10.1007/978-981-16-6077-1_8
157
Chompunud Chompunud Na Ayudhya, Potchanapond Graidist, Varomyalin Tipmanee. Potential Stereoselective Binding of Trans-(±)-Kusunokinin and Cis-(±)-Kusunokinin Isomers to CSF1RMolecules 2022; 27(13): 4194 doi: 10.3390/molecules27134194
158
Anna Maria Badowska-Kozakiewicz, Michał Piotr Budzik. Breast Cancer and Surgery2018;  doi: 10.5772/intechopen.75354
159
Mohammed Moustapha Anwar, Manal Shalaby, Amira M. Embaby, Hesham Saeed, Mona M. Agwa, Ahmed Hussein. Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insightsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71157-w
160
Ileana Castillo-Tobías, Lia Berlanga, Joan Poblano, María del C. Rodríguez-Salazar, Hilda Aguayo-Morales, Luis E. Cobos-Puc. Fundamental Considerations of Targeted Drug Therapies for Breast CancerFuture Pharmacology 2023; 3(4): 686 doi: 10.3390/futurepharmacol3040043
161
Yoser Al Rawi, Saima Shakil Malik, Nosheen Masood. Breast Cancer: From Bench to Personalized Medicine2022; : 403 doi: 10.1007/978-981-19-0197-3_16
162
Amna A. Saddiq, Ali H. El-Far, Shymaa A. Mohamed, Omar A. Almaghrabi, Shaker A. Mousa. Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines’ ProgressionIntegrative Cancer Therapies 2022; 21: 153473542210995 doi: 10.1177/15347354221099537
163
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancerMolecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01805-y
164
Lisa Belfiore, Darren N. Saunders, Marie Ranson, Kristofer J. Thurecht, Gert Storm, Kara L. Vine. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunitiesJournal of Controlled Release 2018; 277: 1 doi: 10.1016/j.jconrel.2018.02.040
165
Mi Li, Spiridon Tsavachidis, Fuchenchu Wang, Tuyen Bui, Tuyen Duong Thanh Nguyen, Linjie Luo, Asha S. Multani, Melissa L. Bondy, Kelly K. Hunt, Khandan Keyomarsi. Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancerOncogene 2022; 41(50): 5331 doi: 10.1038/s41388-022-02527-z
166
Zeyad Alehaideb, Saleh AlGhamdi, Wesam Bin Yahya, Hamad Al-Eidi, Mashael Alharbi, Monira Alaujan, Abeer Albaz, Muruj Tukruni, Atef Nehdi, Maha-Hamadien Abdulla, Sabine Matou-Nasri. Anti-Proliferative and Pro-Apoptotic Effects ofCalligonum comosum(L’Her.) Methanolic Extract in Human Triple-Negative MDA-MB-231 Breast Cancer CellsJournal of Evidence-Based Integrative Medicine 2020; 25: 2515690X2097839 doi: 10.1177/2515690X20978391
167
Arang Kwon, Hyun-Jung Park, Jeong-Hwa Baek. Beta-Catenin Downregulation Contributes to Epidermal Growth Factor-induced Migration and Invasion of MDAMB231 CellsInternational Journal of Oral Biology 2018; 43(3): 161 doi: 10.11620/IJOB.2018.43.3.161
168
Takeo Tatsuta. Basic Research on Bullfrog Egg-derived Sialic Acid-binding Lectin for Cancer TreatmentYAKUGAKU ZASSHI 2022; 142(10): 1045 doi: 10.1248/yakushi.22-00116
169
Deborah Obehi Onwusah, Elizabeth Bolanle Ojewole, Tawanda Manyangadze, Moses John Chimbari. Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative StudyPatient Preference and Adherence 2023; : 2821 doi: 10.2147/PPA.S416843
170
S. Sriharikrishnaa, Padmanaban S. Suresh, Shama Prasada K.. Optical Polarimetric Modalities for Biomedical ResearchBiological and Medical Physics, Biomedical Engineering 2023; : 307 doi: 10.1007/978-3-031-31852-8_11
171
Yu Deng, Fulun Li, Pinglin He, Yafei Yang, Jin Yang, Yamei Zhang, Junying Liu, Yongping Tong, Qingfeng Li, Xian Mei, Zengyi Shu, Qi Zhao. Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibitionMolecular Carcinogenesis 2018; 57(6): 807 doi: 10.1002/mc.22795
172
Wafaa S. Ramadan, Dana M. Zaher, Alaa M. Altaie, Iman M. Talaat, Adel Elmoselhi. Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance MechanismsInternational Journal of Molecular Sciences 2020; 21(2): 565 doi: 10.3390/ijms21020565
173
Endale Hadgu, Daniel Seifu, Wondemagegnhu Tigneh, Yonas Bokretsion, Abebe Bekele, Markos Abebe, Thomas Sollie, Christina Karlsson, Mats G. Karlsson, Tomi F. Akinyemiju. Distribution and characteristics of androgen receptor (AR) in breast cancer among women in Addis Ababa, Ethiopia: A cross sectional studyPLOS ONE 2020; 15(5): e0232519 doi: 10.1371/journal.pone.0232519
174
MeghaPrem Paramban, Vishnu Asokan, MV Tintu, T Ajayakumar. Clinicopathological factors predictive of pathological response and impact on disease-free survival in breast cancer: Analysis from a tertiary cancer centre in South IndiaJournal of Radiation and Cancer Research 2022; 13(2): 54 doi: 10.4103/jrcr.jrcr_54_21
175
Navid Mohammad Mirzaei, Sumeyye Su, Dilruba Sofia, Maura Hegarty, Mohamed H. Abdel-Rahman, Alireza Asadpoure, Colleen M. Cebulla, Young Hwan Chang, Wenrui Hao, Pamela R. Jackson, Adrian V. Lee, Daniel G. Stover, Zuzana Tatarova, Ioannis K. Zervantonakis, Leili Shahriyari. A Mathematical Model of Breast Tumor Progression Based on Immune InfiltrationJournal of Personalized Medicine 2021; 11(10): 1031 doi: 10.3390/jpm11101031
176
Nuno Lopes, Viviana G. Correia, Angelina S. Palma, Catarina Brito. Cracking the Breast Cancer Glyco-Code through Glycan-Lectin Interactions: Targeting Immunosuppressive MacrophagesInternational Journal of Molecular Sciences 2021; 22(4): 1972 doi: 10.3390/ijms22041972
177
Busra Demir Cetinkaya, Cigir Biray Avci. Molecular perspective on targeted therapy in breast cancer: a review of current statusMedical Oncology 2022; 39(10) doi: 10.1007/s12032-022-01749-1
178
Shailima Rampogu, Thananjeyan Balasubramaniyam, Joon-Hwa Lee. Phytotherapeutic applications of alkaloids in treating breast cancerBiomedicine & Pharmacotherapy 2022; 155: 113760 doi: 10.1016/j.biopha.2022.113760
179
Roshan Dutta, Praveen Guruvaiah, Kiran Kumar Reddi, Suresh Bugide, Dhana Sekhar Reddy Bandi, Yvonne J K Edwards, Kamaljeet Singh, Romi Gupta. UBE2T promotes breast cancer tumor growth by suppressing DNA replication stressNAR Cancer 2022; 4(4) doi: 10.1093/narcan/zcac035
180
Huang Wei Ling. Chakras’ and energies deficiencies in the geneses of breast cancerObstetrics & Gynecology International Journal 2021; 12(2) doi: 10.15406/ogij.2021.12.00551
181
Sammed N. Mandape. Breast Cancer: Current Trends in Molecular Research2022; : 86 doi: 10.2174/9781681089522112010007
182
Mehdi Roshanian Bakhsh, Maryam Peymani, Leila Rouhi, Kamran Ghaedi. PSAT1gene as a biomarker for targeting triple negative breast cancer in presence of RapamycinNucleosides, Nucleotides & Nucleic Acids 2022; 41(2): 166 doi: 10.1080/15257770.2021.2025393
183
Gabriel De la Cruz Ku, Manish Karamchandani, Diego Chambergo-Michilot, Alexis R. Narvaez-Rojas, Michael Jonczyk, Fortunato S. Príncipe-Meneses, David Posawatz, Salvatore Nardello, Abhishek Chatterjee. Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 PatientsAnnals of Surgical Oncology 2022; 29(10): 6163 doi: 10.1245/s10434-022-12133-8
184
Luis M. Ruiz-Manriquez, Cynthia Villarreal-Garza, Javier A. Benavides-Aguilar, Andrea Torres-Copado, José Isidoro-Sánchez, Carolina Estrada-Meza, María Goretti Arvizu-Espinosa, Sujay Paul, Raquel Cuevas-Diaz Duran. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast CancerInternational Journal of Molecular Sciences 2023; 24(12): 9984 doi: 10.3390/ijms24129984
185
Danesh Hassani, Mahmood Jeddi-Tehrani, Parisa Yousefi, Samaneh Mansouri-Fard, Maryam Mobini, Hengameh Ahmadi-Zare, Forough Golsaz-Shirazi, Mohammad Mehdi Amiri, Fazel Shokri. Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodiesCancer Chemotherapy and Pharmacology 2022; 89(3): 347 doi: 10.1007/s00280-021-04390-3
186
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment2021; : 79 doi: 10.1007/978-3-030-68334-4_6
187
Tushar Singh Barwal, Uttam Sharma, Sonali Bazala, Ipsa Singh, Manju Jain, Hridayesh Prakash, Shashank Shekhar, Elise N. Sandberg, Anupam Bishayee, Aklank Jain. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian CancersInternational Journal of Molecular Sciences 2021; 22(8): 4072 doi: 10.3390/ijms22084072
188
Maarten van Eijk, René J. Boosman, Alfred H. Schinkel, Alwin D. R. Huitema, Jos H. Beijnen. Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanesCancer Chemotherapy and Pharmacology 2019; 84(3): 487 doi: 10.1007/s00280-019-03905-3
189
Dayanidhi Raman, Anca Maria Cimpean, Maria Rosaria De Miglio. Editorial: Drug resistance in breast cancer – mechanisms and approaches to overcome chemoresistanceFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1080684
190
Vaishali Kilor, Vipin Dhote, Nidhi Sapkal, Shagufta Khan. Nanotechnology Principles in Drug Targeting and Diagnosis2023; : 145 doi: 10.1016/B978-0-323-91763-6.00014-X
191
Jorge G.T. Zañudo, Steven N. Steinway, Réka Albert. Discrete dynamic network modeling of oncogenic signaling: Mechanistic insights for personalized treatment of cancerCurrent Opinion in Systems Biology 2018; 9: 1 doi: 10.1016/j.coisb.2018.02.002
192
Prakash Bansode, Dattaprasad Pore, Shivaji Tayade, Sandeep Patil, Prafulla Choudhari, Gajanan Rashinkar. Remarkable anti-breast cancer activity and molecular docking studies of ferrocene tethered pyrimidobenzothiazoles and pyrimidobenzimidazolesResults in Chemistry 2023; 5: 100758 doi: 10.1016/j.rechem.2022.100758
193
Neelam Laxman Dashputre, Jayesh D. Kadam, Umesh D. Laddha, Surabhi B. Patil, Pavan B. Udavant, Smita P. Kakad. Targeting breast cancer using phytoconstituents: Nanomedicine-based drug deliveryEuropean Journal of Medicinal Chemistry Reports 2023; 9: 100116 doi: 10.1016/j.ejmcr.2023.100116
194
Manzoor Ahmad Mir, Abrar Yousuf Mir. Therapeutic potential of Cell Cycle Kinases in Breast Cancer2023; : 23 doi: 10.1007/978-981-19-8911-7_2
195
Isabel Monteiro, Samantha Morais, Ana Rute Costa, Luisa Lopes-Conceição, Natália Araújo, Filipa Fontes, Teresa Dias, Susana Pereira, Nuno Lunet. Changes in employment status up to 5 years after breast cancer diagnosis: A prospective cohort studyThe Breast 2019; 48: 38 doi: 10.1016/j.breast.2019.07.007
196
Shubhangi D. Shirsat, Vijaykumar V. Jadhav, Rajaram S. Mane. Nanomedicines for Breast Cancer Theranostics2020; : 33 doi: 10.1016/B978-0-12-820016-2.00003-3
197
Susinjan Bhattacharya. Metabolic Reprogramming and Cancer: 2022Qeios 2022;  doi: 10.32388/CK9VJB.2
198
Mário Esteves, Mariana P. Monteiro, José Alberto Duarte. The effects of vascularization on tumor development: A systematic review and meta-analysis of pre-clinical studiesCritical Reviews in Oncology/Hematology 2021; 159: 103245 doi: 10.1016/j.critrevonc.2021.103245
199
Nicola d'Avanzo, Giulia Torrieri, Patrícia Figueiredo, Christian Celia, Donatella Paolino, Alexandra Correia, Karina Moslova, Tambet Teesalu, Massimo Fresta, Hélder A. Santos. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapyInternational Journal of Pharmaceutics 2021; 597: 120346 doi: 10.1016/j.ijpharm.2021.120346
200
Nilofer Shaikh, Aruna Sivaram, Renu Vyas. Screening of natural product libraries in MCF7 cell line reveals the pro-apoptotic properties of β tetraloneJournal of Biomolecular Structure and Dynamics 2024; 42(2): 876 doi: 10.1080/07391102.2023.2196697
201
Nehad M. Ayoub, Ghaith M. Al-Taani, Amer E. Alkhalifa, Dalia R. Ibrahim, Aymen Shatnawi, Guan-Jun Yang. The Impact of the Coexpression of MET and ESR Genes on Prognosticators and Clinical Outcomes of Breast Cancer: An Analysis for the METABRIC DatasetThe Breast Journal 2024; 2024: 1 doi: 10.1155/2024/2582341
202
Hanyi Fang, Alessandra Cavaliere, Ziqi Li, Yiyun Huang, Bernadette Marquez-Nostra. Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast CancerFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.627693
203
Stuti Roy, Suryendu Saha, Debanil Dhar, Puja Chakraborty, Kumar Singha Roy, Chitranjan Mukherjee, Arnab Gupta, Samir Bhattacharyya, Anup Roy, Sanghamitra Sengupta, Susanta Roychoudhury, Somsubhra Nath. Molecular crosstalk between CUEDC2 and ERα influences the clinical outcome by regulating mitosis in breast cancerCancer Gene Therapy 2022; 29(11): 1697 doi: 10.1038/s41417-022-00494-x
204
Deborah Kirk Walker, Lisa Whitehead. Breast surgery for metastatic breast cancerBritish Journal of Community Nursing 2018; 23(7): 334 doi: 10.12968/bjcn.2018.23.7.334
205
Nasibeh Mohammad Ali Pourradi, Hossein Babaei, Hamed Hamishehkar, Behzad Baradaran, Behrooz Shokouhi-Gogani, Dariush Shanehbandi, Marjan Ghorbani, Yadollah Azarmi. Targeted delivery of doxorubicin by Thermo/pH-responsive magnetic nanoparticles in a rat model of breast cancerToxicology and Applied Pharmacology 2022; 446: 116036 doi: 10.1016/j.taap.2022.116036
206
Sneha Durgapal, Kent Hanson, Samantha K Kurosky, Sharon Kautz, Steve Sison, Christina Cool. Work productivity among patients with metastatic breast cancer in the United StatesExpert Review of Pharmacoeconomics & Outcomes Research 2022; 22(7): 1137 doi: 10.1080/14737167.2022.2108409
207
Ya-Ling Hsu, Meng-Chi Yen, Wei-An Chang, Pei-Hsun Tsai, Yi-Chung Pan, Ssu-Hui Liao, Po-Lin Kuo. CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BBBreast Cancer Research 2019; 21(1) doi: 10.1186/s13058-019-1114-3
208
Guillermo Valdivia, Ángela Alonso-Diez, Dolores Pérez-Alenza, Laura Peña. From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive ReviewFrontiers in Veterinary Science 2021; 8 doi: 10.3389/fvets.2021.623800
209
Ferenc Gallyas, Fadi H. J. Ramadan, Kitti Andreidesz, Eniko Hocsak, Aliz Szabo, Antal Tapodi, Gyongyi N. Kiss, Katalin Fekete, Rita Bognar, Arpad Szanto, Zita Bognar. Involvement of Mitochondrial Mechanisms and Cyclooxygenase-2 Activation in the Effect of Desethylamiodarone on 4T1 Triple-Negative Breast Cancer LineInternational Journal of Molecular Sciences 2022; 23(3): 1544 doi: 10.3390/ijms23031544
210
Isha Bansal, Amit Kumar Pandey, Munindra Ruwali. Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challengesFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1244597
211
Piotr Gierlich, Ana I. Mata, Claire Donohoe, Rui M. M. Brito, Mathias O. Senge, Lígia C. Gomes-da-Silva. Ligand-Targeted Delivery of Photosensitizers for Cancer TreatmentMolecules 2020; 25(22): 5317 doi: 10.3390/molecules25225317
212
Arpit Dave, Daniel Charytonowicz, Nancy J. Francoeur, Michael Beaumont, Kristin Beaumont, Hank Schmidt, Tizita Zeleke, Jose Silva, Robert Sebra. The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment optionsCellular Oncology 2023; 46(3): 603 doi: 10.1007/s13402-022-00765-7
213
Benita S. Katzenellenbogen, Valeria Sanabria Guillen, John A. Katzenellenbogen. Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancerBreast Cancer Research 2023; 25(1) doi: 10.1186/s13058-023-01675-8
214
Rizqah Kamies, Celia P. Martinez-Jimenez. Advances of single-cell genomics and epigenomics in human disease: where are we now?Mammalian Genome 2020; 31(5-6): 170 doi: 10.1007/s00335-020-09834-4